SynthesisLasers in medical science2026
Efficacy of Q-Switched and picosecond lasers for acquired bilateral nevus of Ota-like macules: a systematic review and exploratory dose-response meta-analysis.
Synthesis in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acquired bilateral nevus of Ota-like macules (ABNOM) is a common dermal melanocytosis predominantly affecting East Asian women. Q-switched (QS) and picosecond (PS) lasers are widely used, but their comparative efficacy and dose-response relationships have not been quantified. We conducted the first systematic review and dose-response meta-analysis to compare PS versus QS laser efficacy for isolated ABNOM. Eleven databases were searched from inception to May 27, 2026. Forty studies (50 treatment arms) of predominantly single-arm case series were included. The primary analysis used generalized linear mixed models (GLMM) for ≥ 75% clearance, complemented by dose-response meta-regression with cluster-robust standard errors. Pooled ≥ 75% clearance was 47.8% (95% CI 13.4-84.4) for PS and 53.1% (95% CI 30.3-74.6) for QS lasers (P = 0.95). Each additional treatment session was associated with a 3-fold increased odds of clearance (OR 3.2; 95% CI 2.4-4.3; P < 0.001). As an exploratory analysis, the dose-response relationship was monotonic across sessions 1-7. The PS estimate was fragile, ranging from 47.8% to 88.7% across sensitivity analyses. GRADE evidence certainty was very low. Treatment session number, rather than laser type, appeared more strongly associated with clearance. However, this dose-response finding remains hypothesis-generating due to very low certainty of evidence and requires validation in randomized trials. The absence of a statistically significant difference between laser types does not establish equivalence; PS efficacy estimates were highly fragile and based on sparse data. Wavelength may be an independent determinant of clearance and warrants further comparative study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.